White label – Pompe disease - ClinicalTrials.eu

Study on the Effectiveness of Paclitaxel, Docetaxel, and Oxaliplatin in Patients with Resectable Gastric Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Adenocarcinoma gastric
Investigated Drugs:
Study on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis

Not recruiting

3 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Guselkumab
+3
Study on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension

Not recruiting

3 1 1
Investigated Diseases:
- Pulmonary arterial hypertension
Investigated Drugs:
- Seralutinib
+10
Study on Vedolizumab for Children with Moderate to Severe Ulcerative Colitis

Not recruiting

3 1 1 1
Investigated Drugs:
- Prednisone
- Vedolizumab
Long-Term Safety Study of Valoctocogene Roxaparvovec for Patients with Severe Hemophilia A

Not recruiting

3 1 1 1
Investigated Drugs:
- Valoctocogene Roxaparvovec
Study of ALX148 and Azacitidine for Untreated Higher Risk Myelodysplastic Syndrome Patients

Not recruiting

1 1 1 1
Investigated Diseases:
- Myelodysplastic syndrome
Investigated Drugs:
- Alx148
- Azacitidine
Study Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma

Not recruiting

3 1 1 1
Investigated Drugs:
+2
Study Comparing Lorlatinib and Crizotinib for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
- Lorlatinib
+2
Screening for Hidden Cancer Using FDG PET/CT and Gallium (68Ga) Chloride in Patients Aged 50+ with Unexplained Blood Clots

Not recruiting

3 1 1 1
Investigated Diseases:
- Embolism
- Neoplasm malignant
Investigated Drugs:
- Gallium (68Ga) Chloride
Study on the Long-Term Safety of Tavapadon for Patients with Parkinson’s Disease

Not recruiting

3 1 1
Investigated Diseases:
- Parkinson’s disease
Investigated Drugs:
- Tavapadon
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies